Neoadjuvant combination immunotherapy improves outcomes for early stage non-small cell lung cancer

Suppressive immune cells' metabolic vulnerability may be targeted for cancer immunotherapy

An mRNA vaccine for cancer immunotherapy

To improve immunotherapy, researchers look to shift immune cells' access to sugar